Uveitis Trial, Recruiting (NCT07065747)

Uveitis Trial, Recruiting NCT07065747 Sponsor: Oregon Health and Science University Condition: Uveitis

Printed from Voxsanity (voxsanity.com.au) — NCT07065747 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Uveitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have active eye inflammation and have been diagnosed with one of several specific eye conditions linked to conditions such as spondyloarthritis, juvenile idiopathic arthritis, herpes simplex virus, or other types of uveitis (an inflammation inside the eye).
You have floaters in your vision caused by a condition where the gel inside your eye has pulled away from the back of the eye (called posterior vitreous detachment).
You have healthy eyes with no history of eye inflammation, the gel pulling away from the back of your eye, or any previous eye surgery (for a healthy volunteer/control group).

Who may not be able to join:

You are not able to give your agreement to take part in the study after being informed about it.
You are not able to keep your eye still enough during the eye scanning procedure used in this study.
You are not able to commit to attending all the required visits for the study.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Yan Li, PhD, Oregon Health and Science University

Phone: 503-494-7712

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07065747

Sponsor: Oregon Health and Science University

Phase: Not Applicable

Status: Recruiting

Condition: Uveitis

Trial contact: 503-494-7712

More information: https://clinicaltrials.gov/study/NCT07065747

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have active eye inflammation and have been diagnosed with one of several specific eye conditions linked to conditions such as spondyloarthritis, juvenile idiopathic arthritis, herpes simplex virus, or other types of uveitis (an inflammation inside the eye).
You have floaters in your vision caused by a condition where the gel inside your eye has pulled away from the back of the eye (called posterior vitreous detachment).
You have healthy eyes with no history of eye inflammation, the gel pulling away from the back of your eye, or any previous eye surgery (for a healthy volunteer/control group).

Who may not be able to join:

You are not able to give your agreement to take part in the study after being informed about it.
You are not able to keep your eye still enough during the eye scanning procedure used in this study.
You are not able to commit to attending all the required visits for the study.
You are currently pregnant or breastfeeding.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Oregon Health and Science University

Registry

ClinicalTrials.gov

Start date

1 September 2024

Est. completion

1 September 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Identification & Measurement of Anterior Chamber Cells

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov